期刊文献+

山西省城乡糖尿病视网膜病变患病率及相关因素分析 被引量:7

Prevanlence Risk Factors of Diabetic Retinopathy between Urban and Rural Area in Shanxi Province
下载PDF
导出
摘要 目的:调查山西省城乡2型糖尿病并发糖尿病视网膜病变(diabetic retinopathy,DR)的患病率,探讨DR发生的相关危险因素。方法:对研究对象现场问卷调查及眼底检查,对所调查的数据进行统计学分析。结果:太原市省直机关DR的患病率为7.51%,平遥县农村的DR患病率为18.28%。高经济收入优势比(OR)及95%可信限(95%CI)值:太原为0.209(0.050~0.881),平遥县农村为0.034(0.002~0.563);文化程度OR与95%CI值:太原为0.040(0.004~0.387),平遥县农村为0.033(0.001~0.745);糖尿病病程OR与95%CI值:太原为1.444(1.011~2.063),平遥县农村为2.165(1.178~3.982)均于DR有相关性。结论:山西省太原市DR患病率低于平遥县农村;经济收入,文化程度及糖尿病病程是DR发生的危险因素。 Objective:To investigate the morbidity of diabetic retinopathy(diabetic retinopathy,DR) in type 2 diabetes mellitus,and explore risk factors of DR.Methods: On-site surveys and fundus examination were performed for diabetes mellitus patients,and the survey data were analyzed.Results: The prevalence of DR was 7.51% in Taiyuan provincial authorities,while it was 18.28% in Pingyao County.The odd ratio(OR) and 95% confidence interval(95% CI) of higher income was 0.209(0.050~0.881) in Taiyuan,while 0.034(0.002~0.563) in Pingyao;OR and 95% CI of higher education degree was 0.040(0.004~0.387) in laiyuan,while in Pingyao was 0.033(0.001~0.745).For duration of diabetes,OR and 95% CI in Taiyuan was 1.444(1.011~2.063),in pingyao was 2.165(1.178~3.982),both were related to DR.Conclusions: The prevalence rate of DR are different in urban and rural areas in Shanxi Province.DR in Taiyuan city urban areas is less than Pingyao Country in rural areas.Income,education degree and diabetes course are risk factors of DR.
出处 《中国临床医学》 2010年第3期420-422,共3页 Chinese Journal of Clinical Medicine
基金 山西省卫生厅科技攻关计划项目基金(编号:200816)
关键词 2型糖尿病 糖尿病视网膜病变 患病率 相关因素 Type 2 diabetes Diabetes retinopathy Morbidity Relevant factors
  • 相关文献

参考文献4

  • 1曹向阳,黎蕾.糖尿病性视网膜病变的药物治疗进展[J].中国临床医学,2006,13(2):251-252. 被引量:7
  • 2Kohner EM,Aldington SJ,Stratton IM,et al.United Kingdom prospective diabetes study30 diabetic retinopathy at diagnosis of non-insulin-dependent diabetes mellitus and associated risk factors[J].Arch Ophthalmol,1998,116(3):297-303.
  • 3Sharma S,Oliver-Fernandez A,Liu W,et al.The impact of diabetic retinopathy on health-related quality of life[J].Curr Opin Ophthalmol,2005,16(3):155-159.
  • 4胡海英,鹿斌,张朝云,茅林瑜,宋晓艳,董雪红,杨叶虹,周丽诺,李益明,赵耐青,朱禧星,王宣春,叶红英,胡仁明.上海市中心城区2型糖尿病患者视网膜病变现况调查[J].中华流行病学杂志,2007,28(9):838-840. 被引量:11

二级参考文献22

  • 1张承芬 叶俊杰 等.非胰岛素依赖型糖尿病中年患者的眼底表现[J].中华眼科杂志,1986,22:335-335.
  • 2Leibovitch I,Loewenstein A,Alster Y,et al.Interferon alpha-2a for proliferative diabetic retinopathy after complete laser panretinal photocoagulation treatment[J].Ophthalmic Surg Lasers Imaging,2004,35:16-22
  • 3Millen A,Gruber M,Klein R,et al.Relations of serum ascorbic acid and alpha-tocopherol to diabetic retinopathy in the Third National Health and Nutrition Examination Survey[J].Am J Epidemiol,2003,158:225-233.
  • 4Singh R,Barden A,Mori T,et al.Advanced glycation end-products:a review[J].Diabetologia,2001,44:129-146.
  • 5Gupta A,Gupta V,Thapar S,Bhansali A:Lipid-lowering drug atorvastatin as an adjunct in the management of diabetic macular edema[J].Am J Ophthalmol 2004,137:675-682.
  • 6Jonas J,Sofker A.Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema[J].Am J Ophthalmol,2001,132:425-427.
  • 7Ishida S,Usui T,Yamashiro K,et al.VEGF164 is proinflammatory in the diabetic retina[J].Invest Ophthalmol Vis Sci,2003,44:2155-2162.
  • 8Miyamoto K,Khosrof S,Bursell S,et al.Vascular endothelial growth factor VEGF-induced retinal vascular permeability is mediated by intercellular adhesion molecule-1 ICAM-1[J].Am J Pathol,2000,156:1733-1739.
  • 9Vinorcs SA.Technology evaluation.pegaptanib,Eyetech/Pfizer[J].Current Opinion in Molecular Therapeutics,2003,5 (6):673-679
  • 10Cunningham ET Jr,Adamis AP,Altaweel M,et al.A phase Ⅱ randomized double-masked trial of pegaptanib,an anti-vascular endothelial growth factor aptamer,for diabetic macular edema[J].Ophthalmology,2005,112:1747-1757.

共引文献16

同被引文献99

引证文献7

二级引证文献55

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部